Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
Boehringer Ingelheim
Johnson and Johnson
US Army
Baxter
Harvard Business School
Deloitte
Accenture

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,140,329

« Back to Dashboard

Summary for Patent: 6,140,329
Title: Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence
Abstract:The use of (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-p yrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione, (3S 6R,12aR)-2,3,6,7,12,12a-hexahydro-2,3-dimethyl-6-(3,4-methylenedioxyhenyl) -pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione, and physiologically acceptable salts and solvates thereof, in methods and compositions for the treatment of impotence.
Inventor(s): Daugan; Alain Claude-Marie (Les Ulis, FR)
Assignee: ICOS Corporation (Bothell, WA)
Application Number:08/981,989
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,140,329
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Formulation; Delivery;

Drugs Protected by US Patent 6,140,329

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,140,329

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9514464Jul 14, 1995
PCT Information
PCT FiledJuly 11, 1996PCT Application Number:PCT/EP96/03024
PCT Publication Date:February 06, 1997PCT Publication Number: WO97/03675

International Family Members for US Patent 6,140,329

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 556 ➤ Sign Up
African Regional IP Organization (ARIPO) 9500712 ➤ Sign Up
Argentina 003455 ➤ Sign Up
Austria 169018 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Express Scripts
US Department of Justice
Cerilliant
Boehringer Ingelheim
Colorcon
QuintilesIMS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.